Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
On WRAL at 6 : Hundreds of safety violations in Wake Schools uncovered in WRAL investigation raise questions of student safety.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Oculis Holding AG - Ordinary shares
(NQ:
OCS
)
15.97
+1.94 (+13.83%)
Streaming Delayed Price
Updated: 12:47 PM EDT, Oct 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Oculis Holding AG - Ordinary shares
Oculis Announces Partial Exercise of Underwriters’ Option to Purchase Additional Ordinary Shares
June 13, 2023
From
Oculis SA
Via
GlobeNewswire
Stonegate Healthcare Partners Announces Publishing of a Thematic Report - Beyond VEGF: Therapies Revolutionizing Diabetic Eye Disease
June 01, 2023
Dallas, Texas--(Newsfile Corp. - June 1, 2023) - Stonegate Healthcare Partners (SHP), a healthcare...
Via
Newsfile
Oculis Announces Pricing of $40.25 Million Public Offering of Ordinary Shares
May 31, 2023
From
Oculis SA
Via
GlobeNewswire
Oculis Announces Launch of Proposed Public Offering of Ordinary Shares
May 30, 2023
From
Oculis SA
Via
GlobeNewswire
Oculis to Participate and Present at Upcoming EuDES Meeting
May 24, 2023
From
Oculis SA
Via
GlobeNewswire
Oculis Announces Positive Top Line Results from DIAMOND Stage 1 Phase 3 Trial in Diabetic Macular Edema with OCS-01 Eye Drops
May 22, 2023
From
Oculis SA
Via
GlobeNewswire
Oculis Co-founders Selected as Finalists in European Inventor Award 2023
May 11, 2023
From
Oculis SA
Via
GlobeNewswire
Oculis Opens New Offices in the US and Expands its US Team by Appointing Dr. Fang Li as Senior Vice President, Regulatory Affairs
April 26, 2023
From
Oculis SA
Via
GlobeNewswire
Oculis to Participate at Upcoming Investor Conferences
April 05, 2023
From
Oculis SA
Via
GlobeNewswire
Oculis to Host Conference Call on April 13, 2023 to Discuss Late-Stage Pipeline and Near-Term Clinical Milestones
April 04, 2023
From
Oculis SA
Via
GlobeNewswire
Oculis to Ring Nasdaq Stock Market Opening Bell in Celebration of its Successful Listing
March 22, 2023
From
Oculis SA
Via
GlobeNewswire
Oculis Completes Enrollment in Phase 3 OCS-01 OPTIMIZE Trial
March 16, 2023
From
Oculis SA
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.